Associations of Fenofibrate Therapy With Incidence and Progression of CKD in Patients With Type 2 Diabetes

INTRODUCTION: Abnormalities in lipid metabolism may contribute to the development and progression of chronic kidney disease (CKD) in patients with type 2 diabetes. Fenofibrate induces early and reversible reduction in estimated glomerular filtration rate (eGFR), but it may have protective effects on...

Descripción completa

Detalles Bibliográficos
Autores principales: Frazier, Rebecca, Mehta, Rupal, Cai, Xuan, Lee, Jungwha, Napoli, Sara, Craven, Timothy, Tuazon, Jennifer, Safdi, Adam, Scialla, Julia, Susztak, Katalin, Isakova, Tamara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308372/
https://www.ncbi.nlm.nih.gov/pubmed/30596172
http://dx.doi.org/10.1016/j.ekir.2018.09.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308372/
https://www.ncbi.nlm.nih.gov/pubmed/30596172
http://dx.doi.org/10.1016/j.ekir.2018.09.006

Ejemplares similares